Confirmed Exhibitors
Confirmed Exhibitors
We would like to thank the following companies for their support.
EXHIBITORS
argenx
argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx aims to translate immunology breakthroughs into a world-class portfolio of novel antibody-based medicines. argenx developed and is commercializing the first-and-only approved neonatal Fc receptor (FcRn) blocker in the U.S., the EU and Japan. (https://www.argenx.com)
PTC Therapeutics
PTC Therapeutics is a science-driven, global biopharmaceutical company focused on the discovery and development of clinically differentiated medicines that provide benefits to patients with rare disorders. Our mission is to provide access to best-in-class treatments for patients with little to no treatment options. Learn more about PTC at www.ptcbio.com.
Sarepta Therapeutics
Sarepta Therapeutics is on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. Our focus is on Duchenne and limb-girdle muscular dystrophies, and we have 40+ programs in development across 3 technologies – gene therapy, RNA and gene editing. (https://www.sarepta.com/)